Format

Send to

Choose Destination
Curr Opin Immunol. 2011 Oct;23(5):679-84. doi: 10.1016/j.coi.2011.06.006. Epub 2011 Jul 27.

Regulatory T cells in stem cell transplantation: strategies and first clinical experiences.

Author information

1
Department of Hematology and Oncology, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany. matthias.edinger@klinik.uni-regensburg.de

Abstract

The adoptive transfer of donor-type CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) protects from graft-versus-host disease in murine bone marrow transplantation models. Results from first clinical trials exploring such strategies have recently been presented and seem to confirm the efficacy of Treg for the prevention of this severe complication after allogeneic stem cell transplantation. Further improvements in Treg isolation and in vitro expansion technologies will facilitate the broader exploration of Treg therapies, for example, for the treatment of ongoing graft-versus-host disease or the prevention of graft rejection after solid organ transplantation.

PMID:
21802270
DOI:
10.1016/j.coi.2011.06.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center